Sonia Lain

Sonia Lain is a Professor of Molecular Cancer Pharmacology at the Microbiology, Tumour and Cell Biology department of the Karolinska Institutet in Stockholm (Sweden) and scientific founder of Genase Therapeutics. Sonia completed her postgraduate studies at Centro de Biologia Molecular, Madrid, received an EMBO grant to work at the University of Gothenburg, Sweden, and was group leader at the University of Dundee, Scotland, where she was appointed Senior Lecturer. Between 2015 and 2018, she conducted research at the Science for Life Laboratory, in Sweden, where she carried out studies on new drugs in collaboration with the Chemical Biology Consortium Sweden and the Drug Discovery and Development Platform.